402 related articles for article (PubMed ID: 14752830)
21. Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis.
Freudenberg F; Leonard MR; Liu SA; Glickman JN; Carey MC
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G205-14. PubMed ID: 20430874
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of cholesterol transport in bile from patients with and without cholesterol gallstones.
Pattinson NR; Willis KE; Frampton CM
J Lipid Res; 1991 Feb; 32(2):205-14. PubMed ID: 2066657
[TBL] [Abstract][Full Text] [Related]
23. Fat malabsorption in essential fatty acid-deficient mice is not due to impaired bile formation.
Werner A; Minich DM; Havinga R; Bloks V; Van Goor H; Kuipers F; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G900-8. PubMed ID: 12223350
[TBL] [Abstract][Full Text] [Related]
24. [Cholesterol crystals, cholesterol saturation of bile and biliary lithiasis].
Poupon R; Chrétien Y; Darnis F
Gastroenterol Clin Biol; 1984 Mar; 8(3):260-3. PubMed ID: 6714561
[TBL] [Abstract][Full Text] [Related]
25. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones.
Portincasa P; Di Ciaula A; Vendemiale G; Palmieri V; Moschetta A; Vanberge-Henegouwen GP; Palasciano G
Eur J Clin Invest; 2000 Apr; 30(4):317-24. PubMed ID: 10759880
[TBL] [Abstract][Full Text] [Related]
26. Measurement of cholesterol gallstone growth in vitro.
van Den Berg AA; van Buul JD; Ostrow JD; Groen AK
J Lipid Res; 2000 Feb; 41(2):189-94. PubMed ID: 10681401
[TBL] [Abstract][Full Text] [Related]
27. Mdr P-glycoproteins are not essential for biliary excretion of the hydrophobic heme precursor protoporphyrin in a griseofulvin-induced mouse model of erythropoietic protoporphyria.
Plösch T; Bloks VW; Baller JF; Havinga R; Verkade HJ; Jansen PL; Kuipers F
Hepatology; 2002 Feb; 35(2):299-306. PubMed ID: 11826402
[TBL] [Abstract][Full Text] [Related]
28. Physical chemistry of intestinal absorption of biliary cholesterol in mice.
Wang DQ; Lee SP
Hepatology; 2008 Jul; 48(1):177-85. PubMed ID: 18506855
[TBL] [Abstract][Full Text] [Related]
29. Gallstone disease. Pathogenesis of gallstones: A genetic perspective.
Grünhage F; Lammert F
Best Pract Res Clin Gastroenterol; 2006; 20(6):997-1015. PubMed ID: 17127184
[TBL] [Abstract][Full Text] [Related]
30. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model.
Moschetta A; Bookout AL; Mangelsdorf DJ
Nat Med; 2004 Dec; 10(12):1352-8. PubMed ID: 15558057
[TBL] [Abstract][Full Text] [Related]
31. Mucin and phospholipids determine viscosity of gallbladder bile in patients with gallstones.
Jüngst D; Niemeyer A; Müller I; Zündt B; Meyer G; Wilhelmi M; del Pozo R
World J Gastroenterol; 2001 Apr; 7(2):203-7. PubMed ID: 11819761
[TBL] [Abstract][Full Text] [Related]
32. Quantitation of cholesterol-carrying particles in human gallbladder bile.
Eckhardt ER; van de Heijning BJ; van Erpecum KJ; Renooij W; VanBerge-Henegouwen GP
J Lipid Res; 1998 Mar; 39(3):594-603. PubMed ID: 9548591
[TBL] [Abstract][Full Text] [Related]
33. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis.
Rosmorduc O; Hermelin B; Poupon R
Gastroenterology; 2001 May; 120(6):1459-67. PubMed ID: 11313316
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of mdr2 gene by peroxisome proliferators in the mouse liver.
Miranda S; Vollrath V; Wielandt AM; Loyola G; Bronfman M; Chianale J
J Hepatol; 1997 Jun; 26(6):1331-9. PubMed ID: 9210621
[TBL] [Abstract][Full Text] [Related]
35. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
Uppal H; Zhai Y; Gangopadhyay A; Khadem S; Ren S; Moser JA; Xie W
Hepatology; 2008 Apr; 47(4):1331-42. PubMed ID: 18318438
[TBL] [Abstract][Full Text] [Related]
36. Role of phospholipase A2 in cholesterol gallstone formation is associated with biliary phospholipid species selection at the site of hepatic excretion: indirect evidence.
Hattori Y; Tazuma S; Yamashita G; Ochi H; Sunami Y; Nishioka T; Hyogo H; Yasumiba S; Kajihara T; Nakai K; Tsuboi K; Asamoto Y; Sakomoto M; Kajiyama G
Dig Dis Sci; 2000 Jul; 45(7):1413-21. PubMed ID: 10961723
[TBL] [Abstract][Full Text] [Related]
37. Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation.
Wang HH; Afdhal NH; Gendler SJ; Wang DQ
J Lipid Res; 2004 Mar; 45(3):438-47. PubMed ID: 14703511
[TBL] [Abstract][Full Text] [Related]
38. Arachidyl amido cholanoic acid (Aramchol) is a cholesterol solubilizer and prevents the formation of cholesterol gallstones in inbred mice.
Gilat T; Leikin-Frenkel A; Goldiner L; Laufer H; Halpern Z; Konikoff FM
Lipids; 2001 Oct; 36(10):1135-40. PubMed ID: 11768158
[TBL] [Abstract][Full Text] [Related]
39. Review: pathogenesis of gallstones.
Dowling RH
Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():39-47. PubMed ID: 10903002
[TBL] [Abstract][Full Text] [Related]
40. Biliary Polyunsaturated Fatty Acids and Telocytes in Gallstone Disease.
Pasternak A; Bugajska J; Szura M; Walocha JA; Matyja A; Gajda M; Sztefko K; Gil K
Cell Transplant; 2017 Jan; 26(1):125-133. PubMed ID: 27502173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
